The trafficking of TPO-R and how this can be altered in disease has become particularly topical since the discovery that the majority of MPN cases of ET and MF where MPL or JAK2 is not mutated harbor mutations in the gene for the endoplasmic reticulum (ER) chaperone CALR. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.